Novo Nordisk Shares Decline Amid Competitive Pressure
Novo Nordisk Shares Decline Amid Competitive Pressure
Novo Nordisk A/S Common Stock (NYSE:NVO) experienced a notable decline on Thursday. This movement follows a significant announcement from competitor Viking Therapeutics Inc. (NASDAQ:VKTX).
週四，諾和諾德A/S普通股（紐約證券交易所代碼：NVO）大幅下跌。這一舉措是在競爭對手維京療法公司（納斯達克股票代碼：VKTX）發佈重要聲明之後採取的。
What To Know: Viking Therapeutics announced the company has advanced its obesity candidate VK2735 into late-stage trials. This advancement has intensified competition in the GLP-1 market, which is currently led by Novo Nordisk and Eli Lilly corp. (NYSE:LLY).
須知：Viking Therapeutics宣佈，該公司已將其肥胖候選藥物 VK2735 推進到後期試驗。這一進展加劇了 GLP-1 市場的競爭，該市場目前由諾和諾德和禮來公司領導。（紐約證券交易所代碼：LLY）。
Viking Therapeutics' report of promising results for its obesity drug, showing up to a 15% reduction in body weight over 13 weeks, has pressured Novo Nordisk. This development challenges Novo Nordisk's leading position in the obesity treatment market.
Viking Therapeutics報告稱，其肥胖藥物的結果令人鼓舞，顯示在13周內體重減少了15％，這給諾和諾德帶來了壓力。這一發展挑戰了諾和諾德在肥胖治療市場的領先地位。
What Else: The options market for Novo Nordisk has shown a predominantly bearish sentiment recently. Out of eight detected trades, 62% were bearish, including three put options totaling $155,555 and five call options amounting to $255,360.
還有什麼：諾和諾德的期權市場最近表現出以看跌情緒爲主。在檢測到的八筆交易中，有62％看跌，其中包括總額爲155,555美元的三筆看跌期權和總額爲255,360美元的五筆看漲期權。
Novo Nordisk's trading volume reached 1,568,565, with the stock nearing oversold conditions according to RSI indicators. The company's next earnings report is expected in 13 days.
根據RSI指標，諾和諾德的交易量達到1,568,565美元，該股接近超賣狀態。該公司的下一份收益報告預計將在13天后發佈。
Analyst Opinions: Cantor Fitzgerald recently downgraded Novo Nordisk to 'Overweight' but maintained a price target of $160.
分析師觀點：坎託·菲茨傑拉德最近將諾和諾德的評級下調至 “增持”，但將目標股價維持在160美元。
NVO Price Action: Novo Nordisk shares were down by 2.88% at $127.86 according to Benzinga Pro.
NVO價格走勢：根據Benzinga Pro的數據，諾和諾德股價下跌2.88％，至127.86美元。
- Can Independent Bank Corp. Run Higher on Rising Earnings Estimates?
- 隨着收益預期的上升，獨立銀行能否走高？
Photo via Shutterstock.
照片來自 Shutterstock。